Acquisition Has Love Pharma’s Naltrexone on NIH Shortlist to Unmet Medical Need
03 Nov 2022 //
GLOBENEWSWIRE
Naltrexone Demonstrates Promising Long COVID Application
20 Oct 2022 //
ACCESSWIRE
Love Pharma moves to buy transdermal opioid-use disorder player
18 Oct 2022 //
FIERCEPHARMA
Johns Hopkins University Psilocybin Trial Advances Toward Launch in 2022
13 Oct 2022 //
ACCESSWIRE
Love Pharma’s Investment in US Biotech Offers Strategic Industry Advantages
08 Sep 2022 //
GLOBENEWSWIRE
Love Pharma Announces Closing of MicroDoz Therapy Acquisition
13 May 2022 //
ACCESSWIRE
Love Pharma Inc. Announces Closing of Financing
06 May 2022 //
ACCESSWIRE